Log In
BCIQ
Print this Print this
 

urine NGAL test

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionUrine test which detects lipocalin (LCN2; NGAL) biomarker produced in the kidneys
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationRenal, Diagnostic
Indication DetailsDiagnose acute kidney injury (AKI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today